Neuro-Oncology Practice · 2022 · 14 citations · 33 references
MedicineNeurologyOncologyNeuro-oncologyNeuropsychiatrySleep MedicineBrain TumorsExcessive Daytime SleepinessSleep AssessmentSleep DisturbanceSleep-related FactorsSleep-wake DisordersAnxiety Symptom BurdenCancer-related Sleep DisturbanceKarnofsky Performance StatusPrimary Brain NeoplasmsPsychological Symptom BurdenSleep Disturbance BurdenSleep Disturbance In CancerSleep Disturbance Severity
Background: Sleep disturbance (SD) is common in patients with cancer and has been associated with worse clinical outcomes. This cross-sectional study explored the prevalence of SD in a primary brain tumor (PBT) population, identified associated demographic and clinical characteristics, and investigated co-occurrence of SD with other symptoms and mood disturbance. Methods: -tests were used to report results. Results: The sample included 424 patients (58% male, 81% Caucasian) with a mean age of 49 years (range 18-81) and 58% with high-grade gliomas. Moderate-severe SD was reported in 19% of patients and was associated with younger age, poor Karnofsky Performance Status, tumor progression on MRI, and active corticosteroid use. Those with moderate-severe SD had higher overall symptom burden and reported more moderate-severe symptoms. These individuals also reported higher severity in affective and mood disturbance domains, with 3 to 4 times higher prevalence of depressive and anxiety symptoms, respectively. The most frequently co-occurring symptoms with SD were, drowsiness, and distress, though other symptoms typically associated with tumor progression also frequently co-occurred. Conclusions: PBT patients with moderate-severe SD are more symptomatic, have worse mood disturbance, and have several co-occurring symptoms. Targeting interventions for sleep could potentially alleviate other co-occurring symptoms, which may improve life quality for PBT patients. Future longitudinal work examining objective and detailed subjective sleep reports, as well as underlying genetic risk factors, will be important.
33
The two‐process model of sleep regulation: a reappraisal
Alexander A. Borbély, Serge Daan, Anna Wirz‐Justice et al. · Journal of Sleep Research · 2016 · 1.6K citations · Full text
Marie‐Christine Mormont, James Waterhouse, Pascal Bleuzen et al. · PubMed · 2000 · 435 citations
Medicine, Oncology, Chemotherapy +14
The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy
Youqiong Ye, Yu Xiang, Fatma Muge Ozguc et al. · Cell Systems · 2018 · 347 citations · Full text
Life Sciences, Genetics, Oncology +17